Evaluating follow-up strategies for asymptomatic patients after heart surgery
Official title: Assessment in a Randomized Controlled Trial of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up.
Run by Assistance Publique - Hôpitaux de Paris · NCT04566497 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is testing if regular check-ups without stress tests are just as safe and effective for heart surgery patients who don’t have symptoms, compared to those who do have stress tests.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 2664 (estimated) |
| Sponsor | Assistance Publique - Hôpitaux de Paris Academic / other |
| Locations | 1 site (Paris) |
| Trial ID | NCT04566497 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are asymptomatic patients with a history of coronary revascularization who are stable on their current medical treatment.
✕Probably not a fit
Patients with recent acute coronary syndrome or those exhibiting symptoms suggestive of angina will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This trial assesses whether clinical follow-up without systematic stress testing is as effective as regular stress testing for asymptomatic patients who have undergone coronary revascularization. It aims to determine if avoiding stress tests can prevent major cardiac events without compromising patient safety. The study will compare outcomes such as death, heart attacks, and strokes between the two follow-up strategies over a long-term period. By randomizing participants, the trial seeks to provide evidence on the best approach for monitoring these patients.
Why it matters
Potential benefit: If successful, this study could lead to more cost-effective and safer follow-up care for patients after coronary revascularization.
How similar studies have gone: While there is limited evidence from randomized trials on this specific approach, the study aims to fill a gap in knowledge regarding follow-up strategies for asymptomatic patients.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Prior coronary revascularization (PCI or CABG) at any time before randomization. 2. Asymptomatic at the time of randomization (defined as a Canadian Cardiovascular Society score ≤ 1, stable on the current medical treatment). 3. Patient affiliated to Social Security 4. Informed, written consent from the patient Exclusion Criteria: 1. Age \< 18years 2. Any acute coronary syndrome in the previous 3 months 3. Symptoms suggestive of angina pectoris at the time of randomization: * Angina is characterized by ischemic chest pain occurring on exertion or stress relieved by rest and/or nitroglycerine. * Angina equivalents are defined as dyspnea, fatigue, or diaphoresis on exertion evaluated by the principal investigator as abnormal and attributable to myocardial ischemia. 4. Any severe valvular disease 5. Prior heart transplantation 6. Class III or IV symptomatic heart failure (NYHA classification). 7. Persons whose occupations impact on public safety (e.g. airline pilots, lorry or bus drivers) in whom systematic stress testing could be required for medico-legal reasons 8. Malignancies and other comorbid conditions with a life expectancy \< 2 years 9. Pregnancy or nursing women 10. Women of childbearing age without effective birth control or intention to become pregnant during the course of the trial 11. Simultaneous enrollment in an interventional clinical trial and interventional research with minimal risks and burden 12. Inability to sign an informed consent. Patient under legal protection (guardianship, curatorship) or mental condition (psychiatric or organ cerebral disease) rendering the subject unable to understand the nature, scope, and possible consequences of the trial or mental retardation or language barrier such that the patient is unable to give informed consent
Where it's running
-
Pitie salpetriere
Paris, France Recruiting
Study contacts
- Principal investigator: Nadjib Hammoudi, MD PHD — Aphp(assistance Publique Des Hopitaux de Paris
- Study coordinator: Nadjib Hammoudi, MD PHD
- Email: nadjib.hammoudi@aphp.fr
- Phone: 01 42 16 55 35
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Aspirin 50 mg vs 100 mg with a P2Y12 inhibitor after PCI
This trial tests whether a 50 mg daily aspirin dose, when used with a P2Y12 inhibitor after PCI, works as well as 100 mg with similar safety for people staying on DAPT for 12 months.
-
CCTA-Guided CABG vs CAG-Guided CABG
This study tests whether planning CABG with a non-invasive CCTA scan works as well as planning with the standard invasive CAG approach for people with blocked heart arteries.
-
Long-term P2Y12 inhibitor monotherapy and blood clotting after angioplasty
This trial will test whether specific P2Y12 drugs and reduced doses given alone keep platelet activity in a safe therapeutic range for people who completed initial dual antiplatelet therapy after PCI.
-
What affects bleeding control and how long you need to lie flat after femoral arterial sheath removal
We will see if patient and procedure factors can predict how long ICU patients need compression and bed rest after femoral arterial sheath removal to prevent bleeding and hematoma.
-
Doctors' and patients' preferences for PCI implantation devices
This questionnaire tests what patients who have had PCI and the doctors who treat them prefer between drug-eluting stents and drug-coated balloons.
-
How patients and doctors value different outcomes after coronary stent procedures
This project asks patients who had a coronary stent (PCI) and the doctors who treat them to rate how important different possible outcomes are to see if their priorities match.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.